uNGAL Predictive Value for Serum Creatinine Decrease in Critically Ill Children

Area of Science:

• Pediatric Nephrology
• Critical Care Medicine
• Biomarker Research

Background:

• Acute kidney injury (AKI) affects up to 26.9% of critically ill children, increasing morbidity and mortality in pediatric intensive care units (PICUs).
• Current AKI diagnosis relies on serum creatinine, which has a 48-hour delay in detecting renal injury.
• Urinary neutrophil gelatinase-associated lipocalin (uNGAL) shows promise in early AKI detection, particularly after cardiopulmonary bypass in children.

Purpose of the Study:

• To evaluate the utility of uNGAL in managing critically ill pediatric patients.
• To assess uNGAL's capacity to predict AKI development, alone and with the renal angina index (RAI).
• To investigate uNGAL's role in a six-month study of pediatric intensive care unit admissions.

Main Methods:

• Inclusion of twenty-eight critically ill children (1 day to 15 years old).
• Monitoring of uNGAL levels on day 1 and day 3 of pediatric intensive care unit admission.
• Correlation analysis of uNGAL with creatinine clearance and assessment of AKI prediction with and without the renal angina index (RAI).

Main Results:

• An increase in day 1 uNGAL correlated significantly with decreased creatinine clearance.
• This correlation was not observed for uNGAL levels on day 3.
• uNGAL, alone or combined with RAI, did not significantly predict AKI development in this sample.

Conclusions:

• The efficacy of uNGAL in managing critically ill children, outside of cardiac surgery contexts, remains questionable.
• Current findings suggest uNGAL's utility for AKI prediction in this population is limited.
• Larger studies incorporating additional biomarkers (KIM-1, cystatin, IL-18) are necessary for improved AKI prediction models in pediatric intensive care.